Mathieu B.
- Country
- France
- Department
- Savoie
Research Overview
- Phase III Randomized Study of Induction Chemotherapy with Modified DCF Regimen Followed by Chemoradiotherapy vs. Standard Chemoradiotherapy in Locally Advanced Anal Squamous Cell Carcinoma
- Evaluation of Lenvatinib, Pembrolizumab, and Chemotherapy in Advanced/Metastatic Gastroesophageal Adenocarcinoma: A Phase 3 Randomized Study
- Efficacy and Safety of Zolbetuximab with Nab-Paclitaxel and Gemcitabine in Claudin 18.2 Positive Metastatic Pancreatic Adenocarcinoma
Data & Insights
Has run more than one trial at 107 of 277 partner sites.
Specializations
Gastrointestinal Oncology
Focuses on advanced therapeutic approaches for gastroesophageal adenocarcinoma and pancreatic cancer, investigating innovative combination treatments including targeted therapies and immunotherapy agents.
- Metastatic Pancreatic Adenocarcinoma Management
- Advanced Gastroesophageal Cancer Treatment
- Novel Combination Therapies
Particular interest in CLDN18.2-positive tumors and their targeted treatment approaches.
Colorectal Cancer Treatment
Specializes in the treatment of high-risk stage III colon cancer and locally advanced rectal carcinoma, with emphasis on optimizing adjuvant therapy strategies.
- Adjuvant Treatment Protocols
- Neoadjuvant Chemotherapy
- Treatment De-escalation Strategies
Expert in tailoring treatment approaches based on patient response to therapy.
Anal Cancer Research
Investigates treatment protocols for locally advanced anal squamous cell carcinoma, focusing on combined modality approaches.
- Induction Chemotherapy Protocols
- Chemoradiotherapy Applications
- Disease-Related Survival Outcomes
Specializes in evaluating modified chemotherapy regimens in combination with radiotherapy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.